Skip Navigation

DRUG RECORD

 

FESOTERODINE

OVERVIEW
Fesoterodine

 

Introduction

Fesoterodine is an anticholinergic and antispasmotic agent used to treat urinary incontinence and overactive bladder syndrome.  Fesoterodine has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury.

 

Background

Fesoterodine (fes" oh ter' oh deen) is anticholinergic agent which blocks the muscarinic acetylcholine receptors, particularly those found in the smooth muscle of the bladder.  Fesoterodine increases bladder capacity and decreases bladder contractions and the urgency of urination.  Fesoterodine is formulated in an extended release formulation and has a quarternary ammonium group that makes it less likely to cross the blood brain barrier.  Fesoterodine was approved for use in the United States in 2008, and indications include urinary urge incontinence and overactive bladder syndrome.  Fesoterodine is available in tablets of 4 and 8 mg under the brand name Toviaz.  The recommended adult oral dose is 4 to 8 mg once daily.  Common side effects are those of parasympathetic stimulation and include dryness of the mouth and eyes, decreased sweating, headache, visual blurring, constipation, and urinary retention.  Because of its structure, fesoterodine is believed to be less likely than other anticholinergic agents to cause central nervous system effects such as restlessness, confusion and hallucinations.  Anticholinergic agents can precipitate acute narrow angle glaucoma and acute urinary retention.

 

Hepatotoxicity

Like most anticholinergic agents, fesoterodine has not been linked to episodes of liver enzyme elevations or clinically apparent liver injury.  Fesoterodine is metabolized in the liver via the cytochrome P450 system (CYP 2D6 and 3A4).  Its relative safety may relate to its relatively low daily dose.

 

References on the safety and potential hepatotoxicity of anticholinergics are given together after the Overview section on Anticholinergic Agents.

 

Drug Class:  Anticholinergic Agents

 

Top of page


PRODUCT INFORMATION
Fesoterodine

 

REPRESENTATIVE TRADE NAMES
Fesoterodine – Toviaz®

 

DRUG CLASS
Anticholinergic Agents

 

COMPLETE LABELING

Product labeling at DailyMed, National Library of Medicine, NIH

 

Top of page


DRUG CAS REGISTRY NUMBER MOLECULAR FORMULA STRUCTURE
Fesoterodine 286930-02-7 C26-H37-N-O3 Fesoterodine Chemical Structure

Top of page


OTHER REFERENCE LINKS
Fesoterodine
  1. PubMed logoRecent References on Fesoterodine

  2. Clinical Trials logoTrials on Fesoterodine

Top of page